TRC Global Rankings
Menu
TRC Global Rankings
Racing
Jockeys, Owners and Trainers
Breeding and Sales
Welfare
Commentary
Lasix
1
2
>
>|
View From The Rail
These 2-year-old races are the first major step towards solving America’s Lasix obsession
Charles Hayward
|
May 26, 2020
|
Racing
Should horses be given race-day Lasix? Racing insiders have their say
John Gilmore
|
Jan 20, 2020
|
View From The Rail
Lasix: the last thing we should do is kick the can down the road one more time
Charles Hayward
|
Nov 5, 2019
|
Jockeys, Owners and Trainers
Christophe Clement: dealing with the frustration of still being a Breeders’ Cup nearly man
Karen M Johnson
|
Oct 29, 2019
|
Commentary
How phasing out U.S. race-day medication may affect the European sales market
Geir Stabell
|
Oct 16, 2019
|
What They’re Thinking
What Jonathan Sheppard loves about racing - and what he wishes had never been invented
Bob Ehalt
|
Aug 7, 2018
|
View From The Rail
View from the Rail: forget Lasix for now - let’s solve the fundamental issue first
Charles Hayward
|
Apr 24, 2018
|
Racing
How would U.S. racing work in a brave new drug-restricted world?
Daniel Ross
|
Apr 17, 2017
|
Racing
A champion of reform, but the NTRA ‘must remain neutral on Barr-Tonko’
Amanda Duckworth
|
Aug 18, 2016
|
Breeding and Sales
Drugs and medication in racing: ‘it’s like the Mad Hatter’s tea party’
John Gilmore
|
Mar 18, 2016
|
1
2
>
>|
Keep up-to-date with all the latest news and views
Join the TRC Mailing List
Areas of Interest
All
Racing
Breeding
Wagering
Owners / Trainers / Jockeys
Equine Welfare
* Required field
Privacy Policy
Sign Up
I would like to receive news and special offers from carefully selected partners of Thoroughbred Racing Commentary